These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10568557)

  • 1. Pharmacologic approaches to therapy for vasovagal syncope.
    Calkins H
    Am J Cardiol; 1999 Oct; 84(8A):20Q-25Q. PubMed ID: 10568557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trials of neurally mediated syncope.
    Brignole M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S64-9. PubMed ID: 12950522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasovagal syncope: an update on the latest pharmacological therapies.
    Schleifer JW; Shen WK
    Expert Opin Pharmacother; 2015 Mar; 16(4):501-13. PubMed ID: 25534874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
    Aminorroaya A; Tavolinejad H; Sadeghian S; Jalali A; Alaeddini F; Emkanjoo Z; Mollazadeh R; Bozorgi A; Oraii S; Kiarsi M; Shahabi J; Akbarzadeh MA; Rahimi B; Joharimoghadam A; Mohsenizade A; Mohammadi R; Oraii A; Ariannejad H; Apakuppakul S; Ngarmukos T; Tajdini M
    Am Heart J; 2021 Jul; 237():5-12. PubMed ID: 33689731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the prevention of syncope trial IV: assessment of midodrine.
    Raj SR; Faris PD; McRae M; Sheldon RS
    Clin Auton Res; 2012 Dec; 22(6):275-80. PubMed ID: 22610268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatment for vasovagal syncope.
    Kuriachan V; Sheldon RS; Platonov M
    Heart Rhythm; 2008 Nov; 5(11):1609-14. PubMed ID: 18984541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2006; 78(4):64-8. PubMed ID: 16821426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).
    Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W
    Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic prevention of recurrent vasovagal syncope: A systematic review and network meta-analysis of randomized controlled trials.
    Behnoush AH; Yazdani K; Khalaji A; Tavolinejad H; Aminorroaya A; Jalali A; Tajdini M
    Heart Rhythm; 2023 Mar; 20(3):448-460. PubMed ID: 36509319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.
    Romme JJ; Reitsma JB; Black CN; Colman N; Scholten RJ; Wieling W; Van Dijk N
    Cochrane Database Syst Rev; 2011 Oct; (10):CD004194. PubMed ID: 21975744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Europace; 2022 Jul; 24(7):1171-1178. PubMed ID: 35025999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers in syncope: the jury is still out.
    Sheldon RS; Raj SR; Rose S; Connolly SJ
    J Am Coll Cardiol; 2001 Dec; 38(7):2135-6. PubMed ID: 11738330
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of orthostatic hypotension and vasovagal syncope.
    Frishman WH; Azer V; Sica D
    Heart Dis; 2003; 5(1):49-64. PubMed ID: 12549988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope.
    Lamarre-Cliche M
    Am J Cardiovasc Drugs; 2002; 2(1):23-35. PubMed ID: 14727996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.
    Sheldon R; Raj SR; Rose MS; Morillo CA; Krahn AD; Medina E; Talajic M; Kus T; Seifer CM; Lelonek M; Klingenheben T; Parkash R; Ritchie D; McRae M;
    J Am Coll Cardiol; 2016 Jul; 68(1):1-9. PubMed ID: 27364043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine treatment in children with recurrent vasovagal syncope.
    Bagrul D; Ece I; Yılmaz A; Atik F; Kavurt AV
    Cardiol Young; 2021 May; 31(5):817-821. PubMed ID: 33407967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.